Characterization of an angiotensin II-fluorescamine derivative

Development of a new fluorescent angiotensin II probe

Angiotensin II (ANG II) was conjugated to polystyrene Latex fluorescent microspheres (0.5 or 0.05 micron diam) with carbodiimide. Biological activity of the ANG II-conjugated microspheres (ANG II microspheres) was assessed in dispersed hepatocytes. The 0.05 micron ANG II microspheres inhibited glucagon-stimulated adenosine 3',5'-cyclic monophosphate accumulation and stimulated phosphorylase activity in hepatocytes, whereas the 0.5 micron ANG II microspheres only stimulated phosphorylase activity. The biological activity of the ANG II microspheres was caused by the conjugated ANG II and not by "free" ANG II associated with the spheres or by trypsin-like activity of hepatocytes causing release of ANG II from the microspheres. Binding of 0.05 micron ANG II to hepatocytes was readily observed with fluorescence microscopy. Little, if any, binding was observed with microspheres without conjugated ANG II. This fluorescent preparation of ANG II may have great utility in the study of receptor behavior after binding in individual cells.

Biological activity of an angiotensin II--ferritin conjugate on rabbit aortic smooth muscle cells

Specific binding sites for [Asp1,Ile5]angiotensin II (angiotensin) have been demonstrated in homogenates and subcellular fractions of aortic medial smooth muscle cells, but the localization of the angiotensin receptor responsible for contraction has not been determined [Devynck, M. A., & Meyer, P. (1976) Am. J. Med. 61, 758-767]. To establish the location of this receptor, we have prepared a membrane-impermeable analogue of angiotensin by acylating its N-terminal amino group with the N-hydroxysuccinimide ester of succinylated ferritin. This angiotensin-ferritin conjugate possessed the same intrinsic activity as angiotensin but was approximately 200 times less potent in inducing contraction in rabbit aortic strips. The stability of the conjugate was investigated, and approximately 5% of the contractile activity of the angiotensin-ferritin conjugate was attributable to low molecular weight components that were present before or after exposure to aortic strips. The time required for aortic strips to reach a plateau of contraction in response to angiotensin-ferritin was significantly longer than that required by free angiotensin to produce the same level of contraction. With enzymatically dispersed aortic smooth muscle cells, however, the time taken to produce contractions by both angiotensin and angiotensin-ferritin was indistinguishable. [Sar1,-Ala8]angiotensin II, a competitive inhibitor of angiotensin, completely suppressed contractions induced by angiotensin or angiotensin-ferritin in aortic strips or dispersed aortic smooth muscle cells. These results suggest that angiotensin need not directly penetrate the plasma membrane to cause contraction and imply that the angiotensin receptor responsible for initiating contraction of aortic smooth muscle cells is located on the plasma membrane.